• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    EVP, Medicaid Bacon Debra was granted 41 shares and covered exercise/tax liability with 183 shares, decreasing direct ownership by 1% to 12,884 units (SEC Form 4)

    7/2/25 5:14:42 PM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Bacon Debra

    (Last) (First) (Middle)
    2180 HARVARD STREET, SUITE 400

    (Street)
    SACRAMENTO CA 95815

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    MOLINA HEALTHCARE, INC. [ MOH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP, Medicaid
    3. Date of Earliest Transaction (Month/Day/Year)
    06/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/30/2025 A(1) 41 A $247.39(2) 13,067 D
    Common Stock 07/01/2025 F(3) 183 D $306.29 12,884(4) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").
    2. In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2025 of $291.05 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2025, the first date of the ESPP offering period, and (ii) June 30, 2025, the last trading day of the offering period).
    3. The shares were applied to the payment of withholding taxes arising in connection with the vesting of 530 shares on July 1, 2025.
    4. The shares vest as follows: 2,021 shares on March 1, 2026; 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028. The remaining shares are vested.
    Remarks:
    Jeff D. Barlow, by power of attorney for Debra Bacon 07/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MOH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    7/25/2025$210.00Overweight → Neutral
    Cantor Fitzgerald
    7/25/2025$180.00Buy → Hold
    Truist
    7/10/2025$266.00Overweight → Equal-Weight
    Morgan Stanley
    6/9/2025$364.00Overweight
    Morgan Stanley
    4/22/2025$414.00Outperform
    Bernstein
    4/15/2025$375.00Outperform → Neutral
    Robert W. Baird
    3/5/2025$295.00 → $372.00Equal Weight → Overweight
    Wells Fargo
    12/17/2024$378.00 → $350.00Neutral
    Analyst
    More analyst ratings

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Molina Healthcare downgraded by Cantor Fitzgerald with a new price target

      Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00

      7/25/25 8:59:40 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Truist with a new price target

      Truist downgraded Molina Healthcare from Buy to Hold and set a new price target of $180.00

      7/25/25 8:58:38 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Molina Healthcare from Overweight to Equal-Weight and set a new price target of $266.00

      7/10/25 8:36:12 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Molina Healthcare Inc

      10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/24/25 9:49:15 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/23/25 4:17:03 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/7/25 6:31:21 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/14/24 1:22:34 PM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Molina Healthcare Inc

      SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/12/24 12:53:29 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/8/24 10:34:33 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Financials

    Live finance-specific insights

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Woys James was granted 85 shares, increasing direct ownership by 0.13% to 64,331 units (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:55 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Zoretic Richard C was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:19 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Wolf Dale B was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:21:24 PM ET
      $MOH
      Medical Specialities
      Health Care